Bruker Stock Forecast, Price & News

Bruker's stock was trading at $40.00 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, BRKR stock has increased by 50.3% and is now trading at $60.10.
View which stocks have been most impacted by COVID-19.

11 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Bruker in the last twelve months. There are currently 1 sell rating, 5 hold ratings and 5 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" Bruker stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in BRKR, but not buy additional shares or sell existing shares.
View analyst ratings for Bruker or view MarketBeat's top 5 stock picks.

Wall Street analysts have given Bruker a "Hold" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Bruker wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

75 employees have rated Bruker CEO Frank H. Laukien on Glassdoor.com. Frank H. Laukien has an approval rating of 54% among Bruker's employees. This puts Frank H. Laukien in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

Bruker is scheduled to release its next quarterly earnings announcement on Friday, March 26th 2021.
View our earnings forecast for Bruker.

Bruker Co. (NASDAQ:BRKR) posted its earnings results on Saturday, November, 7th. The medical research company reported $0.42 earnings per share for the quarter, topping the Thomson Reuters' consensus estimate of $0.31 by $0.11. The medical research company earned $511.40 million during the quarter, compared to analyst estimates of $485.25 million. Bruker had a trailing twelve-month return on equity of 21.78% and a net margin of 8.04%. The firm's revenue was down 1.9% on a year-over-year basis. During the same quarter last year, the company earned $0.43 EPS.
View Bruker's earnings history.

Bruker declared a quarterly dividend on Friday, November 13th. Shareholders of record on Tuesday, December 1st will be paid a dividend of $0.04 per share on Friday, December 18th. This represents a $0.16 annualized dividend and a yield of 0.27%. The ex-dividend date of this dividend is Monday, November 30th.
View Bruker's dividend history.

Bruker pays an annual dividend of $0.16 per share and currently has a dividend yield of 0.26%. The dividend payout ratio of Bruker is 10.19%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Bruker will have a dividend payout ratio of 9.30% next year. This indicates that Bruker will be able to sustain or increase its dividend.
View Bruker's dividend history.

Bruker issued an update on its fourth quarter 2020 After-Hours earnings guidance on Monday, January, 11th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $620-625 million, compared to the consensus revenue estimate of $586.94 million.

11 Wall Street analysts have issued 12 month target prices for Bruker's stock. Their forecasts range from $27.00 to $64.00. On average, they expect Bruker's share price to reach $48.39 in the next twelve months. This suggests that the stock has a possible downside of 19.5%.
View analysts' price targets for Bruker or view Wall Street analyst' top-rated stocks.

Bruker saw a decline in short interest in the month of December. As of December 31st, there was short interest totaling 1,750,000 shares, a decline of 28.9% from the December 15th total of 2,460,000 shares. Based on an average daily trading volume, of 541,300 shares, the days-to-cover ratio is currently 3.2 days. Approximately 1.7% of the company's shares are short sold.
View Bruker's Short Interest.

Some companies that are related to Bruker include Thermo Fisher Scientific (TMO), Illumina (ILMN), Agilent Technologies (A), Mettler-Toledo International (MTD), Bio-Rad Laboratories (BIO), Waters (WAT), PerkinElmer (PKI), Bio-Techne (TECH), Charles River Laboratories International (CRL), Pacific Biosciences of California (PACB), Luminex (LMNX), Fluidigm (FLDM), Harvard Bioscience (HBIO), aTyr Pharma (LIFE) and BG Medicine (BGMD).
View all of BRKR's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Bruker investors own include AbbVie (ABBV), CVS Health (CVS), Micron Technology (MU), Cisco Systems (CSCO), Intel (INTC), Alibaba Group (BABA), The Walt Disney (DIS), Applied Materials (AMAT), Bank of America (BAC) and Bristol-Myers Squibb (BMY).

Bruker trades on the NASDAQ under the ticker symbol "BRKR."

Bruker's stock is owned by a variety of institutional and retail investors. Top institutional investors include Boston Trust Walden Corp (0.51%), Scout Investments Inc. (0.15%), Candriam Luxembourg S.C.A. (0.04%), Strs Ohio (0.01%), BLB&B Advisors LLC (0.01%) and Nisa Investment Advisors LLC (0.01%). Company insiders that own Bruker stock include Burkhard Prause, Cynthia M Friend, Frank H Laukien, Marc A Kastner and Mark Munch.
View institutional ownership trends for Bruker.

BRKR stock was sold by a variety of institutional investors in the last quarter, including Strs Ohio, and BLB&B Advisors LLC. Company insiders that have sold Bruker company stock in the last year include Cynthia M Friend, and Marc A Kastner.
View insider buying and selling activity for Bruker or view top insider-selling stocks.

BRKR stock was acquired by a variety of institutional investors in the last quarter, including Boston Trust Walden Corp, Candriam Luxembourg S.C.A., Scout Investments Inc., Forte Capital LLC ADV, IBM Retirement Fund, Nisa Investment Advisors LLC, Exchange Traded Concepts LLC, and Global Retirement Partners LLC.
View insider buying and selling activity for Bruker or or view top insider-buying stocks.

Shares of BRKR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of BRKR stock can currently be purchased for approximately $60.10.

Bruker has a market capitalization of $9.20 billion and generates $2.07 billion in revenue each year. The medical research company earns $197.20 million in net income (profit) each year or $1.57 on an earnings per share basis. Bruker employs 7,230 workers across the globe.

The official website for Bruker is www.bruker.com.

Bruker's mailing address is 40 Manning Road, Billerica MA, 01821. The medical research company can be reached via phone at (978) 663-3660 or via email at [email protected]